Pathway Capital Management, LP Day One Biopharmaceuticals, Inc. Transaction History

Pathway Capital Management, LP

  • $29.4 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$18.77 - $22.0 $11.1 Million - $13 Million
592,559 Added 146.99%
995,686 $21.4 Million
Q3 2022

Nov 09, 2022
BUY
$16.44 - $26.57 $6.63 Million - $10.7 Million
403,127 New
403,127 $8.08 Million
Q1 2022

May 10, 2022
SELL
$9.12 - $17.47 $2.21 Million - $4.23 Million
-242,245 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$15.65 - $26.33 $3.79 Million - $6.38 Million
242,245 New
242,245 $4.08 Million

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $986M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email